Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiovascular pharmacogenomics.

Julie A Johnson1, Larisa H Cavallari

  • 1UF Center for Pharmacogenomics, University of Florida, Gainesville, FL, USA. johnson@cop.ufl.edu

Experimental Physiology
|March 22, 2005
PubMed
Summary

Genetics significantly influences how individuals respond to cardiovascular drugs, impacting both efficacy and side effects. Pharmacogenomics aims to personalize drug therapy by understanding these genetic variations for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydrocodone vs Oxycodone and Postoperative Pain and Opioid Use in Joint Arthroplasty.

JAMA network open·2026
Same author

Creation of a Merged Harmonized Large Database of Subject-Level Data from Acute Secondary Prevention Studies in Minor Non-Cardioembolic Stroke or TIA.

International journal of cerebrovascular disease and stroke·2026
Same author

CYP2D6 phenotype and post-surgical pain control with hydrocodone and oxycodone.

Frontiers in pharmacology·2026
Same author

Genotype-Guided Antidepressant Prescribing for Patients With Depression: A Randomized Clinical Trial.

JAMA network open·2026
Same author

The Future of Clinical Translational Pharmacology.

Clinical pharmacology and therapeutics·2026
Same author

Genetic Testing for APOL1 in Adults With Hypertension: The GUARDD-US Randomized Clinical Trial.

JAMA network open·2026

Area of Science:

  • Pharmacogenomics
  • Cardiovascular Pharmacology
  • Genetics

Background:

  • Significant interpatient variability exists in cardiovascular drug response, affecting therapeutic efficacy and causing adverse effects.
  • Genetic factors are increasingly recognized as key contributors to this variable drug response.
  • Pharmacogenomics investigates the genetic basis of drug response to improve therapeutic outcomes.

Purpose of the Study:

  • To review the role of genetic variability in cardiovascular drug efficacy and toxicity.
  • To discuss experimental approaches in cardiovascular pharmacogenomics.
  • To highlight the potential of pharmacogenomics in optimizing cardiovascular drug therapy.

Main Methods:

  • Review of existing literature on genetic associations with drug response.
  • Discussion of candidate gene approaches and genome-wide association studies (GWAS).
  • Exploration of various technologies for genomic data acquisition.

Main Results:

  • Genetic variability in drug-metabolizing enzymes and drug targets influences cardiovascular drug response.
  • Candidate gene approaches identify significant associations but often lack clinical utility.
  • Genome-wide approaches are emerging to provide a more comprehensive understanding of genetic determinants.

Conclusions:

  • Cardiovascular pharmacogenomics holds promise for personalized drug selection based on genetic profiles.
  • Widespread clinical application of genetic information in cardiovascular therapy is likely more than a decade away.
  • Continued research and evolving experimental methods will expand the field's impact.

Related Experiment Videos